| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944561 | Journal of the American Academy of Dermatology | 2018 | 31 Pages |
Abstract
Approximately 12% of patients with BIMTs have germline mutations. Extensive junctional involvement in a BIMT and a personal history of melanoma or previous BIMT may be additional indications for germline testing.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Erin M. BS, Kara E. MD, Victor L. BA, Timothy MD, Bin MS, Betty Y. MD, PhD, Maria Cristina MD, MPH, Elnaz MD, Gene MD, Pedram MD,